Cholesterol inhibits the lytic activity of melittin in erythrocytes

H Raghuraman1, Amitabha Chattopadhyay

  • 1Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad 500 007, India.

Insights

Cholesterol in red blood cell membranes inhibits melittin's cell-damaging (hemolytic) activity. Depleting cholesterol significantly increased melittin's hemolytic effect, revealing cholesterol's protective role.

Area of Science:

  • Biochemistry
  • Membrane Biophysics
  • Toxicology

Background:

  • Melittin, a hemolytic peptide, is known to lyse cells.
  • The specific influence of erythrocyte membrane lipids on melittin's hemolytic activity is not well understood.

Purpose of the Study:

  • To investigate the modulatory effect of cholesterol on melittin-induced hemolysis.
  • To determine if cholesterol in the erythrocyte membrane affects melittin's lytic activity.

Main Methods:

  • Rat erythrocytes were used as the model system.
  • Cholesterol was selectively depleted from erythrocyte membranes using methyl-beta-cyclodextrin (MbetaCD).
  • Hemolytic activity of melittin was measured before and after cholesterol depletion.

Main Results:

  • Depletion of approximately 55% of erythrocyte membrane cholesterol led to a 3-fold increase in melittin's hemolytic activity.
  • Phospholipid composition remained largely unchanged during cholesterol depletion.
  • This study provides the first evidence that cholesterol inhibits melittin's lytic action on the erythrocyte membrane.

Conclusions:

  • Cholesterol plays an inhibitory role in melittin-induced hemolysis.
  • Understanding cholesterol's role is crucial for elucidating melittin's mechanism of action in erythrocyte membranes.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...